UPEXI, INC. (UPXI): M&A transaction — Upexi sells VitaMedica subsidiary for $6M; CEO-controlled entity part of buyer group

UPEXI, INC.

Sold 100% of VitaMedica to group including MFA Holdings (controlled by CEO Allan Marshall) for $6M.
Received $4M cash at closing; $1M promissory note due in 12 months; $1M payable on 15-month anniversary.
Transaction closed June 13, 2024 under SPA dated June 1, 2024.
Upexi retains no ongoing interest in VitaMedica.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

UPEXI, INC. completed a disposition involving Nutra Products LLC, MFA Holdings Corp., and 1000915944 Ontario Inc. for $6,000,000 (closed 2024-06-13).

Action: disposition
Counterparty: Nutra Products LLC, MFA Holdings Corp., and 1000915944 Ontario Inc.
Consideration: $6,000,000
Closing: 2024-06-13

Exact text from the filing

Stock Purchase Agreement dated June 1, 2024. MFA Holdings, Corp. is controlled by Allan Marshall, the Company’s CEO and Chairman. The purchase price in the sale transaction was $6,000,000, of which (i) $4,000,000 was paid in cash at closing, (ii) $1,000,000 is in the form of promissory notes issued by the Buyers to the Company, which promissory notes are payable in

View on SEC.gov

24 m&a transactions filed in the last 30 days. Browse all m&a transactions →

UPEXI, INC. filing history →

Source: SEC EDGAR

accession 0001477932-24-003725

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.